This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2021 Apr 19;6(1):161.

doi: 10.1038/s41392-021-00540-4.

Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Fan Zhang^#¹, Rui Gan^#¹, Ziqi Zhen^#¹, Xiaoli Hu^#², Xiang Li¹, Fengxia Zhou¹, Ying Liu³, Chuangeng Chen¹, Shuangyu Xie¹, Bailing Zhang¹, Xiaoke Wu^{4

5}, Zhiwei Huang⁶

Affiliations

Affiliations

¹ HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China.
² Department of Infectious Diseases, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150030, China.
³ Harbin Blood Center, Harbin, 150056, China.
⁴ Centre for Reproductive Medicine, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150030, China.
⁵ Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
⁶ HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China. huangzhiwei@hit.edu.cn.

^# Contributed equally.

PMID: 33875639
PMCID: PMC8054129
DOI: 10.1038/s41392-021-00540-4

Published Erratum

Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Fan Zhang et al. Signal Transduct Target Ther. 2021.

. 2021 Apr 19;6(1):161.

doi: 10.1038/s41392-021-00540-4.

Authors

Fan Zhang^#¹, Rui Gan^#¹, Ziqi Zhen^#¹, Xiaoli Hu^#², Xiang Li¹, Fengxia Zhou¹, Ying Liu³, Chuangeng Chen¹, Shuangyu Xie¹, Bailing Zhang¹, Xiaoke Wu^{4

5}, Zhiwei Huang⁶

Affiliations

¹ HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China.
² Department of Infectious Diseases, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150030, China.
³ Harbin Blood Center, Harbin, 150056, China.
⁴ Centre for Reproductive Medicine, Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin, 150030, China.
⁵ Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
⁶ HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150080, China. huangzhiwei@hit.edu.cn.

^# Contributed equally.

PMID: 33875639
PMCID: PMC8054129
DOI: 10.1038/s41392-021-00540-4

No abstract available

PubMed Disclaimer

Erratum for

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
Zhang F, Gan R, Zhen Z, Hu X, Li X, Zhou F, Liu Y, Chen C, Xie S, Zhang B, Wu X, Huang Z. Zhang F, et al. Signal Transduct Target Ther. 2020 Aug 14;5(1):156. doi: 10.1038/s41392-020-00263-y. Signal Transduct Target Ther. 2020. PMID: 32796814 Free PMC article.

References

1. Zhang F, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct. Target Ther. 2020;5:156. doi: 10.1038/s41392-020-00263-y. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal